About
Built for Indians who want weight loss that actually lasts.
MedAstra exists because the people we know — friends, families, colleagues — kept cycling through crash diets, viral trends and rebound weight gain. GLP-1 changed what's biologically possible. We're building the structure around it.
We're an early-stage team based in India, building MedAstra as a serious GLP-1 weight-management platform — not a meditation app, not a calorie tracker, not a generic wellness brand.
Our model is simple. GLP-1 therapy, guided by qualified clinicians, can quiet appetite and make consistency possible. Around that, we build the tracking, habit systems and AI insights that turn medication-supported weeks into sustainable years.
We don't prescribe through a form. We don't promise overnight results. We don't optimise for engagement. We optimise for the boring thing that actually matters: long-term adherence.
What we believe
- Slow is sustainable. 0.3–0.7 kg per week is healthier than dramatic drops, GLP-1 or not.
- Indian context matters. Tools should respect dal, roti, sabzi, rice — not retrofit a Western template.
- Clinicians lead. GLP-1 decisions are medical decisions, made by qualified clinicians — not by an app.
- Data should help, not haunt. Insights should reduce anxiety, not add to it. No shame-based streaks.
- Privacy is a feature. Your health data is encrypted, scoped to you, and never sold.